Tokyo, Oct. 24 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059520) titled 'Influence of rTMS and rTSMS on pain' on Oct. 23.
Study Type:
Interventional
Study Design:
Basic Design - Cross-over
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - Kyoto University
Condition:
Condition - Healthy adult
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The aim of the present study is to investigate the influence of rTMS and rTSMS on pain.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - rTMS
Interventions/Control_2 - rTSMS
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - Healthy
Key exclusion criteria - Person who takes medication
Target Size - 56
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 10 Month 23 Day
Date of IRB - 2025 Year 10 Month 23 Day
Anticipated trial start date - 2025 Year 10 Month 23 Day
Last follow-up date - 2029 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068083
Disclaimer: Curated by HT Syndication.
